Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population

Microbiology (United Kingdom)

Volumn 160, Issue PART 5, 2014, Pages 962-969

  Hegerle, N ^a,b   Guiso, N ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ANTIGEN; BACTERIUM ANTIBODY; HEMAGGLUTININ; HEMOLYSIN; PERTACTIN; PERTUSSIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 84899153207     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.074690-0     Document Type: Article

References (48)

1. Advani, A., Van der Heide, H. G., Hallander, H. O. & Mooi, F. R. (2009). Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods 78, 297-301.
2. Barkoff, A. M., Mertsola, J., Guillot, S., Guiso, N., Berbers, G. & He, Q. (2012). Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 19, 1703-1704.
3. Baron, S., Njamkepo, E., Grimprel, E., Begue, P., Desenclos, J. C., Drucker, J. & Guiso, N. (1998). Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 17, 412-418.
4. Betsou, F., Sebo, P. & Guiso, N. (1993). CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun 61, 3583-3589.
5. Bodilis, H. & Guiso, N. (2013). Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg Infect Dis 19, 471-474.
6. Bonmarin, I., Levy-Bruhl, D., Baron, S., Guiso, N., Njamkepo, E., Caro, V. & Renacoq (2007). Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill 12, 678.
7. Bouchez, V., Caro, V., Levillain, E., Guigon, G. & Guiso, N. (2008). Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE 3, e2437.
8. Bouchez, V., Brun, D., Cantinelli, T., Dore, G., Njamkepo, E. & Guiso, N. (2009). First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27, 6034-6041.
9. Carbonetti, N. H. (2010). Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol 5, 455-469.
10. Carbonetti, N. H., Artamonova, G. V., Andreasen, C. & Bushar, N. (2005). Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun 73, 2698-2703.
11. Caro, V., Njamkepo, E., Van Amersfoorth, S. C., Mooi, F. R., Advani, A., Hallander, H. O., He, Q., Mertsola, J., Riffelmann, M. & other authors (2005). Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect 7, 976-982.
12. Caro, V., Hot, D., Guigon, G., Hubans, C., Arrivé, M., Soubigou, G., Renauld-Mongénie, G., Antoine, R., Locht, C. & other authors (2006). Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect 8, 2228-2235.
13. Chenal-Francisque, V., Caro, V., Boursaux-Eude, C. & Guiso, N. (2009). Genomic analysis of the adenylate cyclase-hemolysin Cterminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Res Microbiol 160, 330-336.
14. Cherry, J. D., Tan, T., Wirsing von König, C. H., Forsyth, K. D., Thisyakorn, U., Greenberg, D., Johnson, D., Marchant, C. & Plotkin, S. (2012). Clinical definitions of pertussis: summary of a Global Pertussis Initiative Roundtable Meeting, February 2011. Clin Infect Dis 54, 1756-1764.
15. Coutte, L., Antoine, R., Drobecq, H., Locht, C. & Jacob-Dubuisson, F. (2001). Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J 20, 5040-5048.
16. Fedele, G., Bianco, M. & Ausiello, C. M. (2013). The virulence factors of Bordetella pertussis: talented modulators of host immune response. Arch Immunol Ther Exp (Warsz) 61, 445-457.
17. Gueirard, P., Druilhe, A., Pretolani, M. & Guiso, N. (1998). Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun 66, 1718-1725.
18. He, Q. & Mertsola, J. (2008). Factors contributing to pertussis resurgence. Future Microbiol 3, 329-339.
19. Hegerle, N. & Guiso, N. (2013). Epidemiology of whooping cough & typing of Bordetella pertussis. Future Microbiol 8, 1391-1403.
20. Hegerle, N., Paris, A. S., Brun, D., Dore, G., Njamkepo, E., Guillot, S. & Guiso, N. (2012). Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of bordetellae not expressing pertactin. Clin Microbiol Infect 18, E340-E346.
21. Hegerle, N., Rayat, L., Dore, G., Zidane, N., Bedouelle, H. & Guiso, N. (2013). In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Microbes Infect 15, 399-408.
22. 2 responsive regulon in Bordetella. PLoS ONE 7, e47635.
23. Institut de Veille Sanitaire (1998). Calendrier vaccinal 1998. Bull Epidémiol Hebd 1998, 15.
24. Institut de Veille Sanitaire (2004). Calendrier vaccinal 2004. Bull Epidémiol Hebd 2004, 28-29.
25. Institut de Veille Sanitaire (2008). Calendrier vaccinal 2008. Bull Epidémiol Hebd 2008, 16-17.
26. Jacob-Dubuisson, F. & Locht, C. (2007). The Bordetella adhesins. In Bordetella: Molecular Microbiology. pp. 69-97. Edited by F. C. Locht. Wymondham: Horizon Bioscience.
27. Khelef, N. & Guiso, N. (1995). Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin. FEMS Microbiol Lett 134, 27-32.
28. Khelef, N., Sakamoto, H. & Guiso, N. (1992). Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb Pathog 12, 227-235.
29. Khelef, N., Zychlinsky, A. & Guiso, N. (1993). Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun 61, 4064-4071.
30. Khelef, N., Bachelet, C. M., Vargaftig, B. B. & Guiso, N. (1994). Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect Immun 62, 2893-2900.
31. Ladant, D., Brezin, C., Alonso, J. M., Crenon, I. & Guiso, N. (1986). Bordetella pertussis adenylate cyclase: purification, characterization, and radioimmunoassay. J Biol Chem 261, 16264-16269.
32. Mattoo, S. & Cherry, J. D. (2005). Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18, 326-382.
33. Miyaji, Y., Otsuka, N., Toyoizumi-Ajisaka, H., Shibayama, K. & Kamachi, K. (2013). Genetic analysis of isolates from the 2008-2010 pertussis epidemic in Japan. PLoS ONE 8, e77165.
34. Mooi, F. R., Hallander, H., Wirsing von König, C. H., Hoet, B. & Guiso, N. (2000). Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 19, 174-181.
35. Mooi, F. R., van Loo, I. H., van Gent, M., He, Q., Bart, M. J., Heuvelman, K. J., de Greeff, S. C., Diavatopoulos, D., Teunis, P. & other authors (2009). Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15, 1206-1213.
36. Mooi, F. R., VAN DER Maas, N. A. T. & De Melker, H. E. (2014). Pertussis resurgence: waning immunity and pathogen adaptation-two sides of the same coin. Epidemiol Infect 142, 685-694.
37. Njamkepo, E., Rimlinger, F., Thiberge, S. & Guiso, N. (2002). Thirtyfive years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. Vaccine 20, 1290-1294.
38. Octavia, S., Maharjan, R. P., Sintchenko, V., Stevenson, G., Reeves, P. R., Gilbert, G. L. & Lan, R. (2011). Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection. Mol Biol Evol 28, 707-715.
39. Osickova, A., Masin, J., Fayolle, C., Krusek, J., Basler, M., Pospisilova, E., Leclerc, C., Osicka, R. & Sebo, P. (2010). Adenylate cyclase toxin translocates across target cell membrane without forming a pore. Mol Microbiol 75, 1550-1562.
40. Otsuka, N., Han, H. J., Toyoizumi-Ajisaka, H., Nakamura, Y., Arakawa, Y., Shibayama, K. & Kamachi, K. (2012). Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS ONE 7, e31985.
41. Pawloski, L. C., Queenan, A. M., Cassiday, P. K., Lynch, A. S., Harrison, M. J., Shang, W., Williams, M. M., Bowden, K. E., Burgos-Rivera, B. & other authors (2014). Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 21, 119-125.
42. Perez Vidakovics, M. L., Lamberti, Y., van der Pol, W. L., Yantorno, O. & Rodriguez, M. E. (2006). Adenylate cyclase influences filamentous haemagglutinin-mediated attachment of Bordetella pertussis to epithelial alveolar cells. FEMS Immunol Med Microbiol 48, 140-147.
43. Petersen, R. F., Dalby, T., Dragsted, D. M., Mooi, F. & Lambertsen, L. (2012). Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis 18, 767-774.
44. Plotkin, S. A. (2014). The pertussis problem. Clin Infect Dis 58, 830-833.
45. Queenan, A. M., Cassiday, P. K. & Evangelista, A. (2013). Pertactinnegative variants of Bordetella pertussis in the United States. N Engl J Med 368, 583-584.
46. Quinlan, T., Musser, K. A., Currenti, S. A., Zansky, S. M. & Halse, T. A. (2013). Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013. Mol Cell Probes.
47. Weber, C., Boursaux-Eude, C., Coralie, G., Caro, V. & Guiso, N. (2001). Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 39, 4396-4403.
48. Zaretzky, F. R., Gray, M. C. & Hewlett, E. L. (2002). Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction. Mol Microbiol 45, 1589-1598.